Literature DB >> 3780710

Roxithromycin bioassay procedures for human plasma, urine and milk specimens [corrected and issued with original paging in Eur J Clin Microbiol 1986 Dec;5(6)].

A L Barry, R R Packer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3780710     DOI： 10.1007/bf02017698

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.

Authors:  K V Rolston; B LeBlanc; D H Ho
Journal:  J Antimicrob Chemother       Date:  1986-02       Impact factor: 5.790

2.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

3.  In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.

Authors:  T Barlam; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

4.  In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs.

Authors:  R N Jones; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

5.  In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; A W Howell
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191
  5 in total
  1 in total

1.  Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.

Authors:  R H Gelber; P Siu; M Tsang; L P Murray
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.